10x Genomics, Inc. — Director's Dealing 2024

Aug 26, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2024-08-22

Reporting Person: Saxonov Serge (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-22	Class A Common Stock	S	6749	$22.5297	Disposed	882467	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	27	Indirect
Class A Common Stock	870	Indirect
Class A Common Stock	213250	Indirect
Class A Common Stock	22570	Indirect

Footnotes

F1: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

F2: The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.

F3: The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.

F4: The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.

F5: The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.